Weak (or flaccid) theory and the geographies of sexuopharmaceuticals

A weak theory of economy does not presume relationships between distinct sites of the diverse economy are structured in predictable ways, but observes the ways they are always differently produced according to specific geographies, histories, and ethical practices. This kind of theory does not shy away from the exercise of diverse forms of power (including co-optation, seduction, capture, subordination, cooperation, parasitism, symbiosis, conflict, coexistence, complementarity) that might influence different economic practices. Instead it encourages us to explore their complex spatialities and temporalities (Gibson-Graham, 2006, pp. 71–72).

Weak theory seeks to destabilize grand meta-narratives that claim purchase on the ‘truth’ of how the world works. Instead, this form of theorizing attends to the mundane intersections of economy and politics that occur on a daily basis through the material interactions of individuals and communities across locales without making claims to be able to generalize. It operates through the logic of alterity, finding ways of speaking about economy and politics that deny the totality of capitalism(s).

While it might appear solipsistic, weak theory transgresses the normativities of hard theory, which claims to be ‘all knowing’. I thus offer flaccid theory here as a form of weak theory: it is a way to read the complicated geographies of sex and drug use against the grain of the medicalized (and capitalocentric) logics of hardness and an erectile imperative brought on by sexuopharmaceuticals, their distributions and diffusions, uses, and relationship to sex, sexuality, and sexual health.

This theory is flaccid also because it does not presume to ‘know’ per se, nor does it assume that an erection is an essential state of being male. It operates against the pathologization of erectile flaccidity as a dysfunction and challenges the notion that sex needs to be penetrative, culminating in male ejaculation.4 As a weak theory it validates the flaccid, suggesting that we need not be hard to be active sexual (or social scientific) beings: there are multiple ways (for men) to practice sex that need not include an erection. It also cuts through the binary logics of much social scientific discourse, which tends to cleave apart theory and practice, the theoretical and the empirical (Berg, 1994). Borrowing from Berg (1994, p. 256) flaccid theory suggests that “‘empirical investigations’ are always already theoretical, just as ‘theory’ is always touched by our empirical experiences.”

Flaccid theory, therefore, does not shy away from theoretically discussing the materiality and intimacy of the sexual body—the brain, the hard and soft penis, the clitoris, nipples, anus, vagina, mouth, breasts, and skin—that partially constitute the performative nature of our sexualized identities and subjectivities. Moreover, ‘[a]ttention to the social organization which surrounds [bodily functions such as] urination and bleeding [and the other fluids that seep out, across, and through] … may help us to understand how bodies which do this (in)correctly are categorized and managed by a medicalized society’ (Parr, 2002, p. 247). Reciprocally, flaccid theory suggests that those (in)correct practices may be socially corrected in certain spaces as individuals and communities perform identities through the use of sexuopharmaceuticals in ways that deny and challenge the heterosexualized power dynamics that may underpin their production. This is an intentionally queer project because it challenges the presumptive heteronormativities associated with the development of sexuopharmaceuticals and dysfunction discourses that act as ‘all-encompassing markers of heterosexual competence, now largely detached from reproductive imperatives, but refashioned as integral to responsible and successful self-management’ (Katz and Marshall, 2004, p. 53). As a queer project, flaccid theory challenges the dominant narratives of sexuality present in everyday geographic practice, which tend to privilege the ‘hard’, the ‘masculine’, and the ‘straight.’ Moreover, it suggests that “the queer ‘way of life’ … [which] encompass[es] subcultural practices, alternative modes of alliance, forms of transgender embodiment, and … forms of representation dedicated to capturing these willfully eccentric modes of being” (Halberstam, 2005, p. 1) should be foregrounded in any critical analysis of subjectivity and identity, sex and sexuality, and/or drug use and sexual health. We do not want to normatively assume that Viagra and other sexuopharmaceuticals can be practiced in only one (straight) way and in one particular set of spaces.

Flaccid theory is also critical, engaging how certain social processes ‘exercise diverse forms of power’. This theoretical orientation suggests that the ‘cure’ might very well be creating the ‘problem’, sexuopharmaceuticals help change the meaning of flaccidity—now medicalized as impotence or erectile dysfunction (Katz and Marshall, 2004)—which could have historically been considered to be a natural part of the aging process. Instead, “a mistaken belief that the occasional lack of erection equals ‘impotence’, men and their partners are self-prescribing medications” (Boynton, 2004, p. 3) in a context where ‘most of the current pharmacological literature reviewing Viagra use by men appears to assume an unproblematic link between successful penile erection (and penetration) and user, partner and sexual relationship satisfaction’ (Potts et al., 2003, p. 699).

In the case of sexuopharmaceuticals, bodies defined as, perhaps, medically healthy and erect, might be enhanced by the use of Viagra despite that healthiness. In fact, while Viagra is quite popular among its initial target audience, heterosexual men over 50, it is now used across all sorts of demographics and in ways in which it may never have been intended, such as by both men and women who take these drugs recreationally5 (Aldridge and Measham, 1999; Fisher et al., 2006). So, while Bob Dole’s active support of Viagra in the United States works ironically for and against a conservative agenda of masculine heterosexual power (Loe, 2004b), the drug may be transgressively and normatively queered by a gay man using it in combination with methamphetamines to increase his sexual abilities at a sex party. Similarly, a sex tourist in Southeast Asia might use Viagra to enhance his performance with a commercial sex worker (Bishop and Robinson, 2002). The use of sexuopharmaceuticals is thus a complicated set of practices (Croissant, 2006) that need further consideration as we try to understand how their use constitutes (and encourages) new networks of sexual relations, unique forms and uses of power, and alternative practices of sex and sexual identity.

References
Croissant, 2006 J.L. Croissant, The new sexual technobody: Viagra in a hyperreal world, Sexualities 9 (2006), pp. 333–344. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (1)

Daker-White, 1997 G. Daker-White, ‘Drug users’ access to community-based services, Health and Place 3 (1997), pp. 217–228. Abstract | Abstract + References | PDF (1372 K) | View Record in Scopus | Cited By in Scopus (8)

Dorn and Laws, 1994 M.L. Dorn and G. Laws, Social theory, body politics, and medical geography: extending Kearn’s invitation, The Professional Geographer 46 (1994), pp. 106–110.

Dovey et al., 2001 K. Dovey, J. Fitzgerald and C. Youngju, Safety becomes danger: dilemmas of drug-use in public space, Health and Place 7 (2001), pp. 319–331. SummaryPlus | Full Text + Links | PDF (625 K) | View Record in Scopus | Cited By in Scopus (23)

Elder, 2002 G. Elder, Response to “queer patriarchies, queer racisms, international”, Antipode 34 (2002), pp. 988–991. View Record in Scopus | Cited By in Scopus (8)

Fisher et al., 2006 D.G. Fisher, R. Malow, R. Rosenberg, G.L. Reynolds, N. Farrell and A. Jaffe, Recreational Viagra use and sexual risk among drug abusing men, American Journal of Infectious Diseases 2 (2006), pp. 107–114.

Flory and Kitcher, 2004 J.H. Flory and P. Kitcher, Global health and the scientific research agenda, Philosophy and Public Affairs 32 (2004), pp. 36–65. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (6)

Gibson-Graham, 2006 J.K. Gibson-Graham, A Postcapitalist Politics, University of Minnesota Press, Minneapolis (2006).

Global Insight, 2006 Global Insight, 2006. Pfizer wins landmark Viagra ruling in China. left angle bracketh www. globalinsight.com/SDA/SDADetail6076.htmright-pointing angle bracket (accessed 19 December 2006).

Halberstam, 2005 J. Halberstam, In a Queer Time & Place: Transgendered Bodies, Subcultural Lives, New York University, New York (2005).

Hall, 2000 E. Hall, Blood, brains, and bones’: taking the body seriously in the geography of health and impairment, Area 32 (2000), pp. 21–30.

Hubbard, 2000 P. Hubbard, Desire/disgust: mapping the moral contours of heterosexuality, Progress in Human Geography 24 (2000), pp. 191–217. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (29)

Katz and Marshall, 2004 S. Katz and B. Marshall, Is the functional ‘normal’? Aging, sexuality and the bio-marking of successful living, History of Human Sciences 17 (2004), pp. 53–75. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (4)

Kearns and Moon, 2002 G. Kearns and G. Moon, From medical to health geography: novelty, place and theory after a decade of change, Progress in Human Geography 26 (2002), pp. 605–625.

Kearns, 1993 R. Kearns, Place and health: towards a reformed medical geography, Professional Geographer 45 (1993), pp. 139–147. View Record in Scopus | Cited By in Scopus (101)

Kearns, 1994a R. Kearns, Putting health and health care into place: an invitation accepted and declined, The Professional Geographer 46 (1994), pp. 111–115.

###

Source: Health & Place
Volume 13, Issue 4, December 2007, Pages 904-911

Provided by ArmMed Media